Nyrada, Inc.ASX: NYR

Nyrada US Patent for Xolatryp Granted

· Issued by Nyrada, Inc. via ASX

Filed with ASX ·

Page 1 Nyrada Inc. Level 22/23, Salesforce Tower, 180 George Street, Sydney NSW 2000 ARBN 625 401 818 30 September 2026 Sydney, Australia Nyrada US Patent for Xolatryp® Granted Nyrada Inc. (ASX:NYR), a clinical-stage biotechnology company focused on developing Transient Receptor...

View Attachment

6ix hasn’t read this filing yet.

Nyrada, Inc. on 6ix

Earlier from Nyrada

Later from Nyrada

All Nyrada news releases